Novavax, Inc. is a company in the U.S. stock market and it is a holding in 69 U.S.-traded ETFs. NVAX has around 5.4M shares in the U.S. ETF market. The largest ETF holder of NVAX is the iShares Russell 2000 ETF (IWM), with approximately 1.51M shares. Investors may also find of interest that the ETF with the largest allocation to NVAX stock is ETFMG Treatments Testing and Advancements ETF (GERM), with a portfolio weight of 3.49%. On average, U.S. ETFs allocate 0.34% of NVAX to their portfolios.
Additionally, NVAX is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NVAX as a holding is the Direxion Daily S&P Biotech Bull 3X Shares (LABU), with a return of 109.92%.